On December 03, 2019, The Chemours Company (NYSE:CC) shares lost -2.04% or -0.32 points to close at $15.39 with a heavy trading volume of 3.249 million shares. It opened the trading session at $15.38, the shares rose to $15.51 and dropped to $14.93, the range by which the price of stock traded the whole day. The company now has a market cap of $2.57 billion and currently has 167.12 million outstanding shares. The Chemours Company (CC) stock has plunged -11.35 percent of market value in 21 trading days.
CC stock’s trailing 3-year beta is 2.45, meaning there will be a greater rate of return, although posing a higher risk. The part of a firm’s profit given to each outstanding share of regular stock was $2.39 share in the trailing 52 weeks. The stock’s value fallen -45.46 percent year to date (YTD) compared to a decline of -45.96 percent in 52 week’s period. The firm’s shares are still trading -63 percent below its 1-year high of $41.60 and 31.43 percent up from 52-week low of $11.71. The average consensus ranking on the company is 2.5, on a ranging where 5 is equal to a consensus sell rating. In other words, the mean analyst recommendations are ranking this stock as a sell.
The Chemours Company (CC) is most likely going to rise 62.96 percent in the coming 12 months, as per price target approximations compiled by finviz. Nevertheless, they have set the price target at a $42-month high price target. This represents a whopping 172.9 percent increase from the current trading of shares. The 52-week median price target given by the analysts is $21, which means a return possibility of 36.45 percent in comparison with the closing price of the stock of $15.39 on December 03. The lowest price set for the stock is $15 — just above -2.53 percent from CC share price now.
Past records have indicated that shares in The Chemours Company declined on 9 different earnings reaction days and we have yet to see whether this trend will play out and remain in place when the company reports upcoming earnings. Investors will get the next hint of CC’s Q4 earnings on February 13. Analysts are predicting revenue to suffer decline of -7 percent to $1.36B in the financial fourth quarter, while EPS will soar by about -53.33 percent to $0.49 per share. In the last quarter, it earnings of $0.59 per share came worse than the $1.03014, adjusted, expected by Thomson Reuters consensus estimate. Revenue for the quarter was $1.46B, missing the $1.53B analysts had expected. Earnings are seen to rise by 31.3 percent this year, 35.93 percent in the coming year and the trend continues by -8.8 percent every year in the next 5 years.
Let’s take a glimpse at some insider activity at The Chemours Company (NYSE:CC) and observe the pattern. The earliest insider trade happened on 09/11/2019. Newman Mark gathered a total of 20 thousand shares of the firm at average share price of $16.42. The total amount for the purchase was set at $328.4 thousand. On completing this exchange, the Senior VP & COO account balance was 116.74 thousand shares. The stock lost -6.27 percent from that insider purchase. On 08/07/2019, CRANSTON MARY B, Director, did a purchase of 1.79 thousand shares at a price of $13.99 per share. This increased 25.04 thousand shares to the insider’s fortune and the stock experienced a 10.01 percent rally in price since the news became public. This exchange saw 36.02 thousand shares get into the Director account.
On 08/06/2019, President – Titanium Tech Snell E Bryan recorded a purchase transaction valued at $165.24 thousand. The purchase at $13.77 a share has added 12 thousand shares into the insider’s portfolio position. Meanwhile, shares price witnessed 11.76 percent increase since the transaction reporting date. The company insider is left with 117.77 thousand shares remaining in the account. BELL BRADLEY J, who works as Director at the company, performed a purchase of 5 thousand shares in a transaction worth $73.35 thousand. The acquisition recorded on 08/05/2019 was priced at $14.67 per share. The stock price soared 4.91 percent since the transaction. BELL BRADLEY J currently holds a stake of 53.58 thousand in CC stock which is worth $824.64 thousand after the insider buying.
The stock is lingering around the initial support level of $15.04. After this, the following support is at the zone of $14.7. Up until the time the CC stock hit levels beyond the current one, bulls should have no alarm. In terms of its momentum, the stock’s RSI hit 40.56 on the daily chart, and this may be a cause for concern. In case the price goes below $14.7 level on closing basis, there may be more profit booking with the stock growing weaker. Still, getting to the $15.62 level may cause a pull-back move approaching $15.86 mark.
The Chemours Company (CC) shares are trading at a P/E ratio of 6.4 times earnings posted in the trailing 12 months. The industry CC deals with has an average P/E of 23.6. Its P/B ratio is standing at 3X compared to the 3.4 industry average. It is additionally sporting a 0.5 on the Price-to-Sales ratio, compared to the industry’s P/S average of 1.9. The Chemours Company has a 23.3% gross profit margin, with its operating margin around 9.8%. Alongside this, the company’s net profit margin currently stands at 7.2%.